Trial · NCT03399786
Adverse events160
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 160
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Placebo IV Q4W (DBTP) | 5 | 21 | 6 |
| other | Nasopharyngitis | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 7 | 44 | 7 |
| other | Nasopharyngitis | Infections and infestations | Placebo IV Q4W (OLTP) | 1 | 20 | 2 |
| other | Nasopharyngitis | Infections and infestations | Evinacumab 15 mg/kg (OLTP) | 5 | 44 | 5 |
| other | Urinary tract infection | Infections and infestations | Placebo IV Q4W (DBTP) | 2 | 21 | 3 |
| other | Urinary tract infection | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 0 | 44 | 0 |
| other | Urinary tract infection | Infections and infestations | Placebo IV Q4W (OLTP) | 0 | 20 | 0 |
| other | Urinary tract infection | Infections and infestations | Evinacumab 15 mg/kg (OLTP) | 1 | 44 | 1 |
| other | Gastroenteritis viral | Infections and infestations | Placebo IV Q4W (DBTP) | 0 | 21 | 0 |
| other | Gastroenteritis viral | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 1 | 44 | 1 |
| other | Gastroenteritis viral | Infections and infestations | Placebo IV Q4W (OLTP) | 1 | 20 | 1 |
| other | Gastroenteritis viral | Infections and infestations | Evinacumab 15 mg/kg (OLTP) | 0 | 44 | 0 |
| other | Influenza | Infections and infestations | Placebo IV Q4W (DBTP) | 0 | 21 | 0 |
| other | Influenza | Infections and infestations | Evinacumab 15 mg/kg (DBTP) | 0 | 44 | 0 |
| other | Influenza | Infections and infestations | Placebo IV Q4W (OLTP) | 1 | 20 | 1 |
| other | Influenza | Infections and infestations | Evinacumab 15 mg/kg (OLTP) | 0 | 44 | 0 |
| other | Toothache | Gastrointestinal disorders | Placebo IV Q4W (DBTP) | 2 | 21 | 2 |
| other | Toothache | Gastrointestinal disorders | Evinacumab 15 mg/kg (DBTP) | 2 | 44 | 8 |
| other | Toothache | Gastrointestinal disorders | Placebo IV Q4W (OLTP) | 1 | 20 | 1 |
| other | Toothache | Gastrointestinal disorders | Evinacumab 15 mg/kg (OLTP) | 1 | 44 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03399786/events